State of Founder Mental Health 2026 | CEREVITY Clinical Whitepaper

Clinical Whitepaper · Series No. 04

State of Founder Mental Health 2026

What the evidence says about the psychological cost of building a company, and what to do about it.

Trevor Grossman, PhD Licensed Psychologist Published June 19, 2026
Topic · Founder Mental Health For · Founders, Investors, and Operators Evidence-led vv1.0

Executive summary

Founders are celebrated for endurance, yet the data shows they carry mental health burdens at rates well above the general population. The majority report that building a company has harmed their mental health, most hide it, and only a minority ever seek professional help. This paper reviews the evidence, names the pattern that produces it, and lays out a response that treats founder mental health as infrastructure rather than weakness.

Circumstances

The combination of extreme working hours, financial and reputational stakes, isolation at the top, and an identity fused to the company creates sustained psychological strain that most founders manage privately.

Challenge

Standard mental health options fail founders on privacy, scheduling, stigma, and clinician fit, so the people under the most pressure are the least likely to use them.

Solution

This paper argues for private, expert, flexible care that founders can use without it ever touching their professional record, framed as a performance practice rather than a last resort.

Result

When founders get confidential, well-matched care early, strain is addressed before it degrades judgment or forces a costly exit, protecting both the person and the company.

The problemThe people most celebrated for resilience are, by the numbers, among the most at risk.

The founder mental health problem is not a matter of impression; it is measured. In a 2023 survey of startup founders and CEOs, 72 percent reported that their work had affected their mental health, 37 percent reported anxiety, and 36 percent reported burnout.1 A peer-reviewed study of 242 entrepreneurs found that mental health differences directly or indirectly affected 72 percent of them, with 49 percent reporting a personal mental health history, against a U.S. adult baseline near 23 percent.2,3 Entrepreneurs in that study reported depression at 30 percent and ADHD at 29 percent, both well above the comparison group.2 These are not the numbers of an unusually fragile minority. They describe the typical experience of building a company.

The usual framing misses this because the founder archetype rewards concealment. The same 2023 survey found that 81 percent of founders hide their stress, fears, and challenges from others, and more than half hide it even from their co-founders, while only 23 percent report seeking help from a psychologist or coach.1 Half report a negative stigma around professional mental health support, a stigma that runs higher among younger founders.1 The result is a population that is statistically more likely to be struggling and culturally trained to never show it, which is precisely the combination that lets strain accumulate unseen until it breaks.

The founders most praised for never breaking are often the ones working hardest to hide that they already have. Trevor Grossman, PhD, Licensed Psychologist

The evidenceWhat the research shows

The evidence on founder mental health comes from three streams: peer-reviewed prevalence research comparing entrepreneurs with control groups, large practitioner and investor surveys of working founders, and population baselines from public health bodies. Read together, they establish a consistent pattern. Founders experience elevated rates of psychological strain, they disclose and treat it far less than they experience it, and the costs are both personal and economic. The figures below summarize the strongest of these findings.

72%

of founders report that building their company has negatively affected their mental health

Startup Snapshot, 2023

2.1x

the rate of personal mental-health history among entrepreneurs versus the U.S. adult baseline

Freeman et al., 2019; NAMI

$1T

lost globally each year to depression and anxiety in reduced productivity

WHO, 2024

50%

of CEOs report loneliness in the role, and most say it harms their performance

HBR / RHR, 2012

Three things stand out. First, elevation: across independent sources, founders and entrepreneurs report mental health conditions and acute stress at rates above the general population, not below it. Second, concealment: the gap between how many founders are affected and how many seek help is enormous, driven by a stigma that the founder culture actively reinforces. Third, leverage: because a founder's judgment shapes the company, the cost of their untreated strain concentrates in the decisions everyone else depends on. The pattern is not random distress; it is a predictable consequence of how the role is built and performed.

Table 1. Selected indicators of founder and entrepreneur mental health against general-population benchmarks. · figures are placeholders pending research
Indicator Founders / Entrepreneurs General-population benchmark Source
Any personal mental-health history49%~23% of U.S. adultsFreeman 2019; NAMI
Lifetime depression30%~8% of U.S. adultsFreeman 2019; NIMH
ADHD29%~4.4% of U.S. adultsFreeman 2019; NIMH
Reported high stress in past year85%not directly comparableStartup Snapshot 2023
Anxiety in past year37%-75%~19% of U.S. adultsStartup Snapshot 2023; NIMH
Negative stigma around seeking professional help~50%not directly comparableStartup Snapshot 2023
Sought help from a psychologist or coach23%not directly comparableStartup Snapshot 2023

The frameworkA model you can name and own

A named model helps founders and investors recognize strain while it is still reversible, rather than only naming it after a collapse. The Founder Strain Cascade describes four phases that recur across the founders we see at intake. It is a pattern-recognition tool, not a diagnosis, and its value is that each earlier phase is far easier to address than the one that follows.

CEREVITY model

The Sustained-Performance Burnout Model

A four-phase description of how burnout develops in people whose competence hides it: the better someone performs under load, the later the decline becomes visible. Each phase names a behavior pattern a clinician, a partner, or the person themselves can recognize.

1

Compensation

Output holds steady while the effort behind it quietly doubles. Recovery time shrinks first, before anything visible breaks.

2

Concealment

The strain is managed in private. The person becomes skilled at appearing fine, which delays both their own recognition and anyone else's.

3

Erosion

Sleep, attention, and relationships degrade in sequence. Performance is still defended, but at rising personal cost.

4

Collapse

A threshold is crossed and function drops sharply. By this point the problem is visible to everyone, and far harder to treat than it was three phases earlier.

The practical point of the cascade is timing. Almost every intervention is cheaper, faster, and more effective in the first two phases than in the last. The decision a founder or an investor faces is not whether to act, but whether to act while the cost of acting is still low.

By professionHow it presents across roles

The strain that founders carry is universal in its sources, but it expresses itself differently across the founder lifecycle. The stage a founder is at, and whether they have done this before, changes which pressures dominate and which forms of support actually help. The three segments below describe how the pattern tends to present across the founders we see at intake. These are network-level observations, not diagnoses of any individual.

First-time and solo founders

First-time and solo founders carry the strain with the least scaffolding. They are building the company and learning the role at once, usually without a co-founder to share the weight or a peer who has been through it before. The 2023 founder survey found that 81 percent of founders hide their stress and challenges from others, and isolation is most acute for those without a partner in the work.1 For solo founders, the identity fusion is total: there is no separation between how the company is doing and how the founder feels about themselves, so an ordinary business setback registers as a personal verdict. The financial precarity is often sharpest here too, with personal savings and relationships staked on the outcome. At intake, this group most often presents with anxiety, sleep disruption, and a creeping sense that they cannot tell anyone how close to the edge they feel, because admitting it might frighten the few people backing them. Younger first-time founders also report the highest stigma against seeking help, with stigma higher among founders under 35 than over.1 The practical implication is that this group benefits most from early, private, low-friction access to care, framed not as treatment for a problem but as a normal support for an abnormal load. Catching the strain before it compounds is both easier and more effective at this stage than at any later one.

Funded, scaling-stage founders

Funded, scaling-stage founders trade one set of pressures for another. The existential question of whether the company will exist is replaced by the relentless one of whether it will hit the numbers the last round was raised against. Investor expectations, board scrutiny, and a growing team that depends on the founder for stability all raise the stakes of every decision. Research on founder wellbeing has documented sustained stress at this stage producing burnout, insomnia, and in some cases hospitalization, even as outward signs of success accumulate.5 This group is especially vulnerable to the concealment phase of strain, because the optics of leadership now matter to people whose confidence the company depends on. A founder who would have confided in a friend as a solo operator now feels they cannot show doubt to a board or a team. More than half of founders report receiving no mental health support from their investors, which leaves the people under the most institutional pressure with the least institutional help.6 The loneliness data is relevant here: half of CEOs report loneliness and most say it degrades their performance.4 For this segment, the decisive feature of care is that it be structurally separate from the cap table, so that seeking help carries no perceived risk to the founder's standing. Confidential, expert care that the board never sees is what makes help-seeking possible at this stage.

Serial and post-exit founders

Serial and post-exit founders are often assumed to be immune, having already proven themselves and, in many cases, secured financial freedom. The pattern at intake tells a more complicated story. For founders between ventures or after an exit, the sudden absence of the role can be destabilizing in its own right, removing the structure and identity that organized their lives for years. The peer-reviewed prevalence research is a reminder that the underlying vulnerability does not disappear with success: entrepreneurs as a group show elevated rates of depression and other conditions regardless of outcome.2 Experienced founders also carry the weight of expectation, both their own and others', that they should already know how to manage the strain. That expectation can make a second or third round of difficulty feel like a failure of character rather than a predictable feature of the work, which suppresses help-seeking further. Some in this group struggle with the loss of the intensity itself, finding ordinary life flat after years at high stakes. For this segment, care often focuses less on acute crisis and more on identity, meaning, and the deliberate construction of a life that does not depend on the next venture to feel worth living. The lesson across all three segments is consistent: the strain is a feature of the role, not a flaw in the person, and it responds to care at every stage.

The stakesThe cost of inaction

The cost of founder mental strain is paid in three currencies at once: the founder's own health and relationships, the company's performance and continuity, and the broader economic output lost to untreated mental illness. Each is measurable, and each is larger than the cost of addressing the problem early.

The personal cost

The personal cost is the most direct. In the 2023 founder survey, 45 percent rated their current mental health as bad or very bad, and a majority reported high stress and anxiety over the prior year.1 Founder wellbeing research has documented sustained stress producing burnout, depression, insomnia, and in some cases hospitalization.5 Behind each statistic is a person whose health, sleep, and closest relationships are being spent to keep the company running.

The company cost

The company cost is harder to see but no less real. A founder's strain degrades exactly the capacities the company runs on: judgment, focus, and steadiness under pressure. Half of CEOs report loneliness in the role and 61 percent say it harms their performance, while research on long hours shows diminishing and eventually negative returns from simply working more.4,6 A founder who collapses, checks out, or makes a strain-driven decision can cost a company far more than any program of care would.

The systemic cost

The systemic cost frames the stakes. The World Health Organization estimates that depression and anxiety cost the global economy roughly one trillion dollars a year in lost productivity, with about 12 billion working days lost annually.7 Against that, evidence-based treatment for depression and anxiety returns about four dollars for every dollar invested.8 Founder mental health sits at the high-leverage end of that equation, where small, early investments protect outsized value.

The solutionWhat effective care looks like

Good care for founders has to solve for the specific reasons they avoid it. It must be genuinely private, so that seeking help never appears on an insurance record, a benefits statement, or anywhere a board or investor could see it. It must be flexible enough to fit a calendar that the company effectively controls. It must be delivered by clinicians who understand the realities of building a company, so the founder does not spend the first sessions explaining context. And it must be framed honestly: not as treatment for the broken, but as a performance and resilience practice for people operating under sustained, high-stakes pressure.

This is how CEREVITY is built. CEREVITY is a nationwide network of independent licensed clinicians, matched to the person, delivered by secure video, on a private-pay basis that keeps the work confidential. Sessions run in three formats: 50-minute, 90-minute, and 3-hour intensive. Because care is private-pay, it never generates an insurance claim, a diagnosis code, or an explanation-of-benefits statement, which is the feature that most often makes seeking help possible for a founder at all.

ImplementationHow to put it into practice

Recognizing the problem is not the same as fixing it. The following four steps turn the evidence into a roadmap a founder, an operating team, or an investor can actually act on, ordered so that the earliest and cheapest interventions come first.

  1. 01

    Normalize early, before the metric is collapse

    Treat the early signs of strain as signals to act, not weaknesses to outlast. Shrinking recovery time, sleep disruption, and a growing gap between how a founder appears and how they feel are the first phases of the cascade. Normalizing these as ordinary occupational signals, the way an athlete treats fatigue, makes it possible to act while intervention is still light.

  2. 02

    Decouple care from the cap table

    Keep mental health care structurally separate from the company and its investors. Private-pay care that generates no insurance record, no diagnosis code, and no benefits statement removes the single largest barrier founders report. Care a founder can use without anyone on the cap table ever knowing is care a founder will actually use.

  3. 03

    Match the clinician to the context

    Match founders with clinicians who understand the context of building a company. A generalist with no exposure to founder dynamics, board pressure, or the isolation of the role often produces a poor first experience that ends help-seeking entirely. Fit is not a luxury; it is what makes the care effective and repeatable.

  4. 04

    Build recovery into the operating rhythm

    Design recovery into the operating rhythm rather than hoping it happens. The research is clear that returns from ever-increasing hours diminish and then reverse, and that recovery is what sustains performance. Building genuine downtime, peer support, and clinical access into the company's cadence protects the founder and the company at once.

RecommendationsWhere to start

Clinical

Screen for strain, not just for crisis

Use brief, validated check-ins to surface strain in its early phases, before it presents as crisis. The goal is to catch the cascade at compensation or concealment, where intervention is cheapest and most effective, rather than at collapse.

Clinical

Treat help-seeking as a performance practice

Reframe working with a clinician as part of operating at a high level, the equivalent of physical conditioning or executive coaching. Founders who treat help-seeking as a performance practice use it earlier and benefit more than those who wait for a breakdown.

Structural

Investors should fund confidential, off-record care

Investors who care about returns should fund confidential, off-record mental health care for their founders, with no visibility into who uses it. Over half of founders report no mental health support from their investors; closing that gap protects the investment and the person.

Structural

Build founder peer structures with clinical backing

Pair founder peer communities with clinical backing so that shared experience is supported by professional expertise. Peer structures reduce isolation, and HBR research found that the majority of CEOs who sought peer support reported improved company performance.

FAQCommon questions

Why are founders more affected by mental health conditions than the general population?
The role itself produces it. Building a company combines extreme working hours, high financial and reputational stakes, isolation at the top, and an identity tightly fused to the venture. Peer-reviewed research has found elevated rates of depression, ADHD, and other conditions among entrepreneurs compared with control groups, and large surveys consistently show the majority of founders reporting that their work has harmed their mental health. The combination of high strain and a culture that rewards concealment is what makes the pattern so pronounced.
If most founders are struggling, why do so few get help?
The barriers are structural, not personal. Surveys find that the large majority of founders hide their stress, that around half report a stigma against seeking professional support, and that only a minority ever see a psychologist or coach. Privacy fears, scheduling that the company controls, concern about how investors or boards might perceive it, and a founder culture that prizes appearing unbreakable all combine to suppress help-seeking. Care that is private, flexible, and framed as a performance practice rather than a last resort directly addresses each of these barriers.
Is this whitepaper based on diagnosing individual founders?
No. The patterns described here, including the Founder Strain Cascade, are network-level and population-level observations drawn from published research and aggregate clinical experience, not diagnoses of any individual. CEREVITY clinicians provide individualized assessment and care within a confidential clinical relationship. This document is intended to inform founders, operators, and investors about a measurable pattern, not to label any specific person.
How does private-pay billing work?
CEREVITY operates on a fully private-pay basis. Fees are presented in plain terms before any session is booked, and billing is completed before scheduling. This keeps care free of insurance constraints and protects the confidentiality of the record.
How is my privacy protected?
Sessions are delivered over secure video. Records are held by the treating clinician under their own professional and legal obligations, and information is not shared without your direction except where the law requires it.

MethodologyHow this paper was built

Methodology

This whitepaper synthesizes publicly available, externally published research on founder and entrepreneur mental health, supplemented by aggregate clinical observation. Sources were identified through searches of PubMed, the peer-reviewed literature indexed by Springer and Wiley, World Health Organization publications, the National Alliance on Mental Illness, and large-scale practitioner and investor surveys, covering material published between 2016 and 2026. Search terms included entrepreneur and founder mental health, prevalence of psychiatric conditions among entrepreneurs, founder burnout, CEO loneliness, and the return on investment for mental health treatment. The core prevalence findings draw on Freeman and colleagues' peer-reviewed study of 242 entrepreneurs and 93 comparison participants, published in Small Business Economics in 2019. Survey-based figures on stress, anxiety, burnout, concealment, and help-seeking are drawn primarily from the 2023 Startup Snapshot report of startup founders and CEOs and from founder wellbeing research published by Balderton Capital. Population baselines are taken from the National Alliance on Mental Illness and the U.S. National Institute of Mental Health. Economic figures are drawn from the World Health Organization and from a global return-on-investment analysis published in The Lancet Psychiatry. CEO loneliness figures are drawn from a Harvard Business Review and RHR International survey. Several limitations should be stated plainly. Much of the survey data relies on self-report and on samples that are not nationally representative, so reported rates may reflect who chose to respond. Definitions of stress, burnout, and mental health impact vary across sources and are not always clinically standardized. Comparisons between entrepreneur samples and general-population baselines are approximate because the underlying instruments and time frames differ. The Founder Strain Cascade is a clinical and conceptual model intended to aid recognition; it has not been validated as a diagnostic instrument. Where this document refers to CEREVITY observations, those reflect aggregate, de-identified patterns across the network's intake conversations and are clearly framed as network-level pattern rather than individual diagnosis; no individual client data is presented. All numeric external figures in this paper carry a numbered citation tied to the references below, and readers are encouraged to consult the primary sources directly. Nothing in this document constitutes medical advice or a diagnosis.

References

  1. 01Startup Snapshot. The Untold Toll: The Impact of Stress on the Well-Being of Startup Founders and CEOs. 2023. https://feld.com/archives/2023/05/the-impact-of-stress-on-the-well-being-of-startup-founders-and-ceos/
  2. 02Freeman MA, Staudenmaier PJ, Zisser MR, Andresen LA. The prevalence and co-occurrence of psychiatric conditions among entrepreneurs and their families. Small Business Economics. 2019;53(2):323-342. https://link.springer.com/article/10.1007/s11187-018-0059-8
  3. 03National Alliance on Mental Illness. Mental Health By the Numbers. 2023. https://www.nami.org/mental-health-by-the-numbers/
  4. 04Harvard Business Review and RHR International. Survey on CEO loneliness and performance. 2012. https://hbr.org/2012/02/its-time-to-acknowledge-ceo-lo
  5. 05Balderton Capital. Founder Wellbeing and Performance Research Report. 2024. https://www.balderton.com/wp-content/uploads/2024/10/Founder-Wellbeing-Report-2024.pdf
  6. 06Balderton Capital. Start-up founders under greater pressure than ever as research reveals diminishing returns from ever increasing hours. 2024. https://www.balderton.com/news/start-up-founders-under-greater-pressure-than-ever-as-research-reveals-diminishing-returns-from-ever-increasing-hours/
  7. 07World Health Organization. Mental health at work: fact sheet. 2024. https://www.who.int/news-room/fact-sheets/detail/mental-health-at-work
  8. 08Chisholm D, Sweeny K, Sheehan P, et al. Scaling-up treatment of depression and anxiety: a global return on investment analysis. The Lancet Psychiatry. 2016;3(5):415-424. https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(16)30024-4/fulltext
  9. 09National Institute of Mental Health. Mental Illness statistics. 2023. https://www.nimh.nih.gov/health/statistics/mental-illness
  10. 10World Health Organization and International Labour Organization. WHO guidelines on mental health at work. 2022. https://www.ncbi.nlm.nih.gov/books/NBK586364/
  11. 11Freeman MA. Are Entrepreneurs Touched with Fire? Research summary. 2015. https://michaelafreemanmd.com/Research_files/Are%20Entrepreneurs%20Touched%20with%20Fire-summary.pdf
  12. 12Startup Snapshot. 72% of startup founders report an impact on their mental health. 2023. https://finance.yahoo.com/news/72-startup-founders-report-impact-190904214.html
  13. 13Deloitte and Workplace Intelligence. Advancing Workforce Well-being. 2024. https://www.deloitte.com/us/en/insights/topics/talent/workplace-well-being-research.html
  14. 14Goetzel RZ, Long SR, Ozminkowski RJ, et al. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers. Journal of Occupational and Environmental Medicine. 2004;46(4):398-412. https://journals.lww.com/joem/abstract/2004/04000/health,_absence,_disability,_and_presenteeism_cost.13.aspx
  15. 15Stephan U. Entrepreneurs mental health and well-being: a review and research agenda. Academy of Management Perspectives. 2018;32(3):290-322. https://journals.aom.org/doi/10.5465/amp.2017.0001
  16. 16Vanhove AJ, Herian MN, Perez ALU, Harms PD, Lester PB. Can resilience be developed at work? A meta-analytic review of resilience-building programme effectiveness. Journal of Occupational and Organizational Psychology. 2016;89(2):278-307. https://bpspsychub.onlinelibrary.wiley.com/doi/abs/10.1111/joop.12123
  17. 17World Health Organization. Over a billion people living with mental health conditions; services require urgent scale-up. 2025. https://www.who.int/news/item/02-09-2025-over-a-billion-people-living-with-mental-health-conditions-services-require-urgent-scale-up
  18. 18National Alliance on Mental Illness and Ipsos. The 2025 NAMI Workplace Mental Health Poll. 2025. https://www.nami.org/support-education/publications-reports/survey-reports/the-2025-nami-workplace-mental-health-poll/
https://cerevity.com/wp-content/uploads/2025/11/Trevor-Grossman-PhD-2.jpg

Trevor Grossman, PhD

PhD, Licensed Psychologist · Licensed Psychologist

Dr. Grossman is a Licensed Psychologist with more than 15 years of clinical experience working with entrepreneurs, founders, senior executives, and high-responsibility professionals navigating burnout, anxiety, and depression. His work integrates cognitive behavioral therapy, acceptance and commitment therapy, behavioral activation, and schema-informed approaches calibrated to the working week his clients are actually living in. He sees clients via CEREVITY's nationwide telehealth network.

Talk to someone who gets it.

If this paper describes something you recognize, a confidential conversation is the next step. CEREVITY matches you to an independent licensed clinician who works with people in your position.

Schedule consultation

Private-pay, telehealth, nationwide. Questions: (562) 295-6650

If you are in crisis Call or text 988 (Suicide and Crisis Lifeline). Text HOME to 741741 (Crisis Text Line). Reach NAMI at 1-800-950-NAMI (6264). In an emergency, call 911. CEREVITY is not a crisis service. For non-urgent questions, call (562) 295-6650.
CEREVITY

A nationwide network of independent licensed clinicians. Care is private-pay and delivered by secure video. This whitepaper is for educational purposes and is not medical advice or a substitute for care from a licensed clinician.